Zdrowie i gospodarka · 18/10/2022

FDA Releases Final Guidance for Developing Drugs and Biological Products for Acute Myeloid Leukemia Treatment

The US Food and Drug Administration (FDA) has published a final guidance document to help pharmaceutical companies develop effective treatments for acute myeloid leukemia (AML), a type of blood cancer, and has made it available on its website.